BCBS Louisiana Medical Policy Updates – March 2019

March 2019 BCBS Louisiana Medical Policy Updates: 

• Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast
• Adoptive Immunotherapy
• Aimovig  (erenumab-aooe)
• Aqueous Shunts and Stents for Glaucoma
• asfotase alfa (Strensiq)
• aspirin extended release capsules (Durlaza)
• benralizumab (Fasenra)
• Beta Adrenergic Antagonists and Beta Adrenergic Antagonist/Diuretic Combination Drugs
• Cardiovascular Risk Panels
• Computer-Aided Evaluation of Malignancy with Magnetic Resonance Imaging of the Breast
• emicizumab (Hemlibra)
• Gastric Electrical Stimulation
• Home Uterine Activity Monitoring-Archived Policy
• hydroxyprogesterone caproate Injection (Makena)
• Identification of Microorganisms Using Nucleic Acid Probes
• infliximab-abda (Renflexis)
• infliximab-dyyb (Inflectra)
• Intradialytic Parenteral Nutrition
• Intravenous Anesthetics for the Treatment of Chronic Pain
• KRAS, NRAS and BRAF Variant Analysis in Metastatic Colorectal Cancer
• Light Therapy for Psoriasis
• lomitapide (Juxtapid)
• mepolizumab (Nucala)
• Migraine Medications (Oral, Injectable, Transdermal, and Nasal)
• miltefosine (Impavido)
• mipomersen (Kynamro)
• Moderate Penetrance Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk
• Molecular Analysis for Targeted Therapy of Non-Small-Cell Lung Cancer
• Multianalyte Assays with Algorithmic Analyses for Predicting Risk of Type 2 Diabetes-Archived Policy
• Multimarker Serum Testing Related to Ovarian Cancer
• Multispectral Digital Skin Lesion Analysis
• Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA
• Occlusion of Uterine Arteries Using Transcatheter Embolization or Laparoscopic Occlusion to Treat Uterine Fibroids
• Photocoagulation of Macular Drusen – Archived Policy
• Select Drugs for Attention Deficit Hyperactivity Disorder (ADHD)
• Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy
• Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
• Tetracyclines (oral)
• Topical Acne Cleansers
• Topical Acne Kits
• Topical Pain Patches
• Transcatheter Mitral Valve Repair
• Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
• vigabatrin (Sabril)

Click here to view the Blue Cross Blue Shield Louisiana Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.